Arkowitz David — SEC insider filings
SEC reporting owner CIK 1296999. 25 insider filings on record with FilingPulse; latest filed 2026-10-15.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2020-11-23 to 2026-10-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 18,382 shares, $49,999 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 16,307 shares, $93,451 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 49.
- Largest priced transaction: sale of 6,073 shares @ $11.13 ($67,592) in Flexion Therapeutics Inc, filed 2021-01-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Flexion Therapeutics Inc (FLXN) | Chief Financial Officer | 3 | — | 2 legs · 8,302 sh · $83,708 | 3 |
| iBio, Inc. (IBIO) | Director | 4 | 1 leg · 18,382 sh · $49,999 | — | 3 |
| Seres Therapeutics, Inc. (MCRB) | Chief Financial Officer | 8 | — | 2 legs · 8,005 sh · $9,743 | 18 |
| F-star Therapeutics, Inc. (FSTX) | Director | 4 | — | — | 13 |
| KINETA, INC./DE (KANT) | Director | 6 | — | — | 12 |
Insider filings — Arkowitz David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-15 | 4 | iBio, Inc. (IBIO) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | iBio, Inc. (IBIO) | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | KINETA, INC./DE (KANT) | Disposition to issuer (D): 16,571 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | KINETA, INC./DE (KANT) | Option exercise (M): 12,500 @ $0.61 · Tax withholding (F): 4,706 @ $0.26 · Grant/award (A): 6,000 @ $0 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2025-01-13 | 4 | iBio, Inc. (IBIO) | Purchase (P): 18,382 @ $2.72 | EDGAR |
| 2024-11-25 | 4 | iBio, Inc. (IBIO) | Grant/award (A): 12,600 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | KINETA, INC./DE (KA) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 10,625 · Sale (S): 3,939 @ $1.08 · Grant/award (A): 213,750 (derivative) @ $0 · Grant/award (A): 287,905 (derivative) @ $0 · Grant/award (A): 35,625 (derivative) @ $0 · Option exercise (M): 10,625 (derivative) @ $0 | EDGAR |
| 2023-10-31 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 13,209 @ $0 · Sale (S): 4,066 @ $1.35 · Grant/award (A): 26,418 (derivative) @ $0 · Option exercise (M): 13,209 (derivative) @ $0 | EDGAR |
| 2023-05-01 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 42,500 @ $0 | EDGAR |
| 2023-04-14 | 4 | KINETA, INC./DE (KA) | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2023-03-09 | 4 | F-star Therapeutics, Inc. (FSTX) | Code (U): 8,386 @ $7.12 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Other (J): 10,000 (derivative) · Other (J): 5,500 (derivative) · Other (J): 4,386 (derivative) · +4 more | EDGAR |
| 2023-02-07 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 42,500 (derivative) @ $0 · Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2022-10-31 | 4 | Seres Therapeutics, Inc. (MCRB) | Option exercise (M): 5,000 @ $0 · Grant/award (A): 42,500 @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2022-07-06 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 63,492 @ $3.15 | EDGAR |
| 2022-06-22 | 4 | F-star Therapeutics, Inc. (FSTX) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-02-08 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 190,000 (derivative) @ $0 | EDGAR |
| 2021-06-07 | 4 | F-star Therapeutics, Inc. (FSTX) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | YUMANITY THERAPEUTICS, INC. (YMTX) | Grant/award (A): 14,800 (derivative) @ $0 | EDGAR |
| 2021-06-01 | 4 | Seres Therapeutics, Inc. (MCRB) | Grant/award (A): 270,000 (derivative) @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2021-05-12 | 4 | Flexion Therapeutics Inc (FLXN) | Sale (S): 2,229 @ $7.23 | EDGAR |
| 2021-03-03 | 4 | Flexion Therapeutics Inc (FLXN) | Grant/award (A): 30,000 @ $0 · Grant/award (A): 41,900 @ $0 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-01-07 | 4 | Flexion Therapeutics Inc (FLXN) | Sale (S): 6,073 @ $11.13 | EDGAR |
| 2020-12-28 | 4 | YUMANITY THERAPEUTICS, INC. (YMTX) | Grant/award (A): 4,347 @ $23 | EDGAR |
| 2020-11-23 | 4 | F-star Therapeutics, Inc. (SBPH) | Other (J): 1,096 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1296999 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs